Heron Therapeutics第三季度每股收益$（0.10）错过$（0.01）估计，销售额3，821.3万美元错过3，903.1万美元估计

Heron Therapeutics (NASDAQ: HRTX) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.01) by 900 percent. This is a 233.33 percent decrease over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $38.213 million which missed the analyst consensus estimate of $39.031 million by 2.10 percent. This is a 16.47 percent increase over sales of $32.810 million the same period last year.